Document is current
Any future updates will be listed below
-
Authors
Chen, Oliver https://orcid.org/0009-0002-2154-5651
Prime, Constance
Hooper, William
Vanderzande, Thomas
Alegre, Marita
Rynkiewicz, Anna
Karpińska-Nowak, Anetta
Ghassemi, Annahita
-
Funding
Funding for this research was provided by:
Church and Dwight
- License Information
-
More Information
Article History
Received: 23 February 2026
Accepted: 1 September 2026
First Online: 16 September 2026
Declarations
Ethics approval: Ethical approval for this study was obtained from the Bioethics Committee of the Regional Chamber of Physicians (Gdańsk, Poland). This study was conducted per the ethical principles initially outlined in the Declaration of Helsinki (1964) and according to EN ISO standard 14155:2020 and EU regulation 2017/745 on medical devices and complies with local regulatory requirements.
Consent: Signed informed consent and authorization for the use of protected health information were provided by each participant’s parents/legal guardians before implementing any protocol-specific procedures.
Competing interest: Stérimar™ is a registered trademark of Sofibel S.A.S, a subsidiary of Church & Dwight Ltd. OC is a Senior Clinical Manager at Church & Dwight Co., Inc. CP is an R&D Manager at Church & Dwight Co., Inc. WH is a Statistician at Church & Dwight Co., Inc. TV is a R&D project leader at Church & Dwight Co., Inc. MA is an R&D Senior Director at Church & Dwight Co., Inc. AR and AK were the study investigators at Eurofins have no conflict of interest to declare. AG is a Senior Director for Global Safety and Clinical at Church & Dwight Co., Inc.
